Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Nessa Carey will lead the strategic development and implementation of the Entrepreneur in Residence (EiR) programme in Medical Sciences, laying the foundation of a world-class innovation support ecosystem capable of accelerating the translation of world-leading research into innovative therapies, business and commercial products.

Dr Nessa Carey and Royal Society (logo)

Managed by the MSD Translational Research Office (TRO), the scheme is designed to provide Oxford's research community with access to world-leading expertise and advice across multiple industry sectors in the following themes:

  • Development of compelling translational project/technology strategies
  • Navigating hurdles associated with commercialisation and spin-out, working alongside Oxford University Innovation
  • Sourcing and development of high quality bids for external funding streams

Dr Nessa Carey will bring broad, multi-stakeholder and non-sector specific strategic oversight to the programme. With experience of the biotechnology industry landscape, she has vast knowledge of business, IP and commercialisation strategies across biomedical modalities, and will work with Oxford's academic community to enrich innovative translational programmes with commercial context.

Dr Carey will also work with our Business Partnerships Office and Translational Research Office teams, as well as Oxford University Innovation, to facilitate the recruitment of ‘Experts’ with an in-depth sector-specific knowledge, which they will apply to research programmes to ensure routes to translation are optimised and potential hurdles identified early.

Find out more about the Entrepreneur in Residence scheme and Dr Nessa Carey

About the Royal Society Entrepreneur in Residence (EiR) Scheme

The Royal Society Entrepreneur in Residence (EiR) scheme, part of the Science, Industry and Translation programme, aims to increase the knowledge and awareness in UK universities of cutting edge industrial science, research and innovation. The successful applicants are funded to spend 20% of their time over two years with their host university and collaborators, sharing their experiences to help mentor and support students and academics. The scheme has now funded 49 placements in 29 universities across the UK since its inception in 2018.

Read more on the Royal Society website.

 

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.